Works by Massey, Dan
Results: 12
Characterization of gut microbiomes of household pets in the United States using a direct-to-consumer approach.
- Published in:
- PLoS ONE, 2020, v. 15, n. 2, p. 1, doi. 10.1371/journal.pone.0227289
- By:
- Publication type:
- Article
Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA–KIDNEY.
- Published in:
- Clinical & Experimental Nephrology, 2024, v. 28, n. 6, p. 588, doi. 10.1007/s10157-024-02489-4
- By:
- Publication type:
- Article
EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6.
- Published in:
- 2017
- By:
- Publication type:
- journal article
First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 6, p. 1569, doi. 10.1007/s00432-019-02862-x
- By:
- Publication type:
- Article
Efficacy and safety of tiotropium Respimat® SMI in COPD in two 1-year randomized studies.
- Published in:
- International Journal of COPD, 2010, v. 5, p. 197
- By:
- Publication type:
- Article
Diagnosis of airway obstruction in primary care in the UK: the CADRE (COPD and Asthma Diagnostic/management REassessment) programme 1997-2001.
- Published in:
- International Journal of COPD, 2006, v. 1, n. 4, p. 435, doi. 10.2147/copd.2006.1.4.435
- By:
- Publication type:
- Article
Does EGFR Mutation Type Influence Patient-Reported Outcomes in Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer? Analysis of Two Large, Phase III Studies Comparing Afatinib with Chemotherapy (LUX-Lung 3 and LUX-Lung 6).
- Published in:
- Patient, 2018, v. 11, n. 1, p. 131, doi. 10.1007/s40271-017-0287-z
- By:
- Publication type:
- Article
Phase II Study of Afatinib as Third-Line Treatment for Patients in Korea With Stage IIIB/IV Non-Small Cell Lung Cancer Harboring Wild-Type EGFR.
- Published in:
- Oncologist, 2014, v. 19, n. 7, p. 702, doi. 10.1634/theoncologist.2013-0419
- By:
- Publication type:
- Article
Lansoprazole and amoxycillin: Observations on the treatment of Helicobacter pylori infection.
- Published in:
- Journal of Gastroenterology & Hepatology, 1997, v. 12, n. 2, p. 93, doi. 10.1111/j.1440-1746.1997.tb00390.x
- By:
- Publication type:
- Article
XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease.
- Published in:
- Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01649-w
- By:
- Publication type:
- Article
Deploying Cryptography in Internet-Scale Systems: A Case Study on DNSSEC.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non-small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX-Lung 3.
- Published in:
- Cancer Science, 2015, v. 106, n. 9, p. 1202, doi. 10.1111/cas.12723
- By:
- Publication type:
- Article